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Fructose-1,6-bisphosphate couples glycolytic ﬂux
to activation of Ras
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Carmen Bravo Gonzalez-Blas 1,2, Veerle Janssens 5, Peter Tompa3,4, Wim Versées3,4
& Johan M. Thevelein 1,2
Yeast and cancer cells share the unusual characteristic of favoring fermentation of sugar over
respiration. We now reveal an evolutionary conserved mechanism linking fermentation to
activation of Ras, a major regulator of cell proliferation in yeast and mammalian cells, and
prime proto-oncogene product. A yeast mutant (tps1Δ) with overactive inﬂux of glucose into
glycolysis and hyperaccumulation of Fru1,6bisP, shows hyperactivation of Ras, which causes
its glucose growth defect by triggering apoptosis. Fru1,6bisP is a potent activator of Ras in
permeabilized yeast cells, likely acting through Cdc25. As in yeast, glucose triggers activation
of Ras and its downstream targets MEK and ERK in mammalian cells. Biolayer interferometry
measurements show that physiological concentrations of Fru1,6bisP stimulate dissociation of
the pure Sos1/H-Ras complex. Thermal shift assay conﬁrms direct binding to Sos1, the
mammalian ortholog of Cdc25. Our results suggest that the Warburg effect creates a vicious
cycle through Fru1,6bisP activation of Ras, by which enhanced fermentation stimulates
oncogenic potency.
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Yeast is one of the most prominent examples of eukaryoticcells, which displays under aerobic conditions high fer-mentative activity as well as rapid cell proliferation, just
like mammalian cancer cells1. Warburg suggested that high gly-
colytic activity may be causally related to the cancerous state2,
while in yeast high glycolytic activity also correlates with the most
rapid cell proliferation. There is a striking correlation between the
rate of uncontrolled cell proliferation, the aggressive metastasis
character of cancers and the extent of the ‘Warburg effect’3, 4. In
spite of many studies, however, it remains controversial whether
strong fermentation is a cause or a symptom of cancer since no
clear molecular link between glycolysis and proteins controlling
cell proliferation has been identiﬁed5.
Yeast and mammalian cells also share the G-protein and
oncogene product, Ras, with a homologous set of regulators,
Cdc25,Sdc25/Sos1 and Ira1,2/NF1, but with different target pro-
teins, adenylate cyclase in yeast and, e.g., the Raf protein kinase in
mammalian cells6–8. Ras is highly conserved. Mammalian Ras can
functionally replace yeast Ras9 and hyperactive Ras oncogenes
cause aberrant cell proliferation control and apoptosis induction
in yeast10, 11. Mutant RAS genes, encoding overactive (perma-
nently GTP loaded) Ras proteins, are among the most common
oncogenes found in naturally occurring and artiﬁcially induced
cancer cells12. Ras also serves as an important regulator of cell
proliferation in yeast acting through activation of cAMP synthesis
and the protein kinase A (PKA) pathway (Fig. 1)6. Glucose is a
potent activator of cAMP synthesis and thus of protein kinase A
(PKA) in yeast, and this is mediated by Cdc25/Ras in concert with
a glucose-sensing G-protein coupled receptor system (Fig. 1)13–
18. Glucose catabolism in glycolysis is required for cAMP sig-
naling and activation of the Ras proteins (Fig. 1)15, 19 but the
underlying mechanism has been unclear. The strong conservation
of Ras and its regulators, Cdc25,Sdc25/Sos1 and Ira1,2/NF1, in
yeast and mammalian cells, suggests that the unknown
mechanism responsible for glycolytic activation of Ras may also
be conserved in the two cell types.
In nearly all cells, glucose is phosphorylated by hexokinase or
glucokinase to glucose-6-phosphate (Glu6P) after its transport
into the cells, then converted to fructose-6-phosphate (Fru6P) by
phosphoglucoisomerase and subsequently phosphorylated to
Fru1,6bisP by phosphofructokinase 1 (Fig. 1). Fru1,6bisP is by far
the most elaborately controlled glycolytic metabolite since its
biosynthetic and hydrolytic enzymes are post-translationally
controlled by multiple mechanisms, including a speciﬁc allos-
teric regulator, Fru2,6bisP, which is synthesized and hydrolyzed
in a parallel regulatory pathway20. Fru1,6bisP is split into the
triose phosphates dihydroxyacetone phosphate (DHAP) and
glyceraldehyde-3-phosphate (GAP), which are ultimately con-
verted into pyruvate, and further into a fermentation product,
either ethanol in yeast (Fig. 1) or lactic acid in mammalian cells.
Multiple molecular changes have been identiﬁed in cancer cells
contributing to the high glycolytic rate, including enhanced
intrinsic activity of phosphofructokinase 1 and higher levels of its
allosteric activator Fru2,6bisP3, 21, 22. Hexokinase activity has also
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Fig. 1 Schematic overview of initial glucose metabolism in yeast and its connection to activation of the Ras-cAMP-PKA pathway. Extracellular glucose is
transported by facilitated diffusion into the cells after which it is phosphorylated by one of the two hexokinases or by glucokinase. The activity of the two
hexokinases, but not glucokinase, is feedback-inhibited by Tre6P, the intermediate in trehalose biosynthesis. Glu6P is further converted into Fru6P,
Fru1,6bisP, the triose phosphates DHAP and GAP, and the latter is subsequently converted to pyruvate and the fermentation product ethanol. Galactose is
taken up by its own carrier, phosphorylated to Gal1P and further converted into Glu6P, where it joins the glucose catabolic pathway, effectively bypassing
the hexokinase catalyzed step in glycolysis. The Ras-cAMP-PKA pathway exerts major control over cell proliferation, fermentation rate, stress tolerance
and developmental pathways in yeast. As in mammalian cells, cAMP is synthesized by adenylate cyclase (Cyr1) and binds to the Bcy1 regulatory subunits
of PKA, causing their dissociation from the catalytic Tpk subunits with activation of the latter as result. Yeast adenylate cyclase is activated by a glucose-
sensing G-protein coupled receptor (GPCR) system, composed of the Gpr1 receptor, the Gα protein Gpa2, and its GAP factor Rgs2, similar to activation of
adenylate cyclase by GPCR systems in mammalian cells. As opposed to mammalian cells, however, yeast adenylate cyclase is also activated by the Ras1,2
proteins, which are controlled by the Cdc25 (and Sdc25) guanine nucleotide exchange factor (GEF) and the GTPase activating proteins (GAP) Ira1,2. Ras
and its regulators are highly conserved between yeast and mammalian cells (the GEF Sos and the GAP NF1, respectively). Although it was known that
glucose catabolism in glycolysis is required for glucose activation of the Ras proteins and cAMP synthesis, the molecular connection remained unknown. In
the present paper, it is shown that Fru1,6bisP functions as activator of Ras by interacting with Cdc25 and that this connection between glycolysis and Ras is
conserved between yeast and mammalian cells
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received particular attention as one of the major determinants of
the Warburg effect. In certain types of cancer cells, type II hex-
okinase is strongly associated with the mitochondrial ADP/ATP
carrier, losing its feedback inhibition by glucose-6P and allowing
much higher catalytic activity due to efﬁcient coupling with
mitochondrial ATP provision3. When such cancer cells were
grown on galactose, a sugar whose metabolism does not involve
hexokinase, the high fermentation rate was strongly reduced23.
Subsequent work showed that this alteration of type II hexokinase
was sufﬁcient to enhance the glycolytic rate of a normal cell up to
that observed in cancer cells24. Extensive additional evidence has
highlighted the critical role of type II hexokinase in aberrant
glycolytic metabolism of cancer cells3.
Whereas mammalian hexokinase is feedback-inhibited by its
product Glu6P25, yeast hexokinase is feedback inhibited by
trehalose-6-phosphate (Tre6P) (Fig. 1)26. Tre6P is synthesized
from Glu6P and UDPG by Tre6P synthase (Tps1) as intermediate
of trehalose biosynthesis (Fig. 1). Tps1Δ cells have unbridled
hexokinase activity and display uncontrolled inﬂux of glucose
into glycolysis27. This is characterized by hyperaccumulation of
metabolites upstream of glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) in the upper part of glycolysis, especially
Fru1,6bisP, and rapid depletion of ATP, phosphate and glycolytic
metabolites downstream of GAPDH. As a result the tps1Δ strain
is unusually sensitive to low amounts (a few mM) of glucose28, 29.
Deletion of hexokinase 2, the most active hexokinase isoenzyme
in yeast, completely suppresses aberrant glucose catabolism and
restores growth on glucose of the tps1Δ strain30. Since galactose
metabolism uses galactokinase rather than hexokinase for con-
version of galactose into Glu6P and entry at this point into gly-
colysis, tps1Δ cells do not show deregulated glycolysis with
galactose as substrate and grow normally on galactose. Hence, in
a certain sense, tps1Δ cells resemble cancer cells with unrestricted
hexokinase activity, although their fermentation defect is much
more severe, causing complete absence of growth on glucose.
In the present work, we have made use of the yeast tps1Δ
mutant to identify the molecular connection between glucose
fermentation and activation of Ras. We provide extensive evi-
dence for an evolutionary conserved mechanism between yeast
and mammalian cells in which Fru1,6bisP functions in physio-
logical concentrations as a potent activator of the Ras proteins,
acting through its Cdc25/Sos1 guanine nucleotide exchange fac-
tor. This ﬁnding suggests that the Warburg effect, i.e., the elevated
fermentation rate in cancer cells, creates a vicious cycle through
Fru1,6bisP activation of Ras, causing enhanced fermentation rate
to stimulate oncogenic potency.
Results
Glucose triggers apoptosis through Ras. We show that glucose
addition to galactose-grown tps1Δ cells triggers rapid and dra-
matic activation of Ras, as opposed to the modest activation
observed in wild type cells (Fig. 2a). The GTP loading state on
Ras in the tps1Δ strain, 10 min after glucose addition, is similar to
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Fig. 2 Glucose triggers activation of Ras and apoptosis in tps1Δ cells. a Ras-GTP level before and 10min after addition of glucose (glu) to cells grown on
galactose (gal). The strain expressing Ras2val19 was grown on glucose. Total Ras= Ras-GDP + Ras-GTP. Quantiﬁcation of the signals as Ras-GTP level/total
Ras level compared to the ratio for wild type or tps1Δ on galactose set at 1.0. The values were determined through quantiﬁcation by densitometry and are
expressed as relative arbitrary units. b Speciﬁc cytochrome c release from the mitochondria after addition of glucose to wild type and tps1Δ strain. M,
mitochondrial fraction; SN, post-mitochondrial supernatant; Anti-CyC, anti-cytochrome c antibody; Anti-Cox2, cytochrome oxidase 2 antibody; C: control
cytochrome c or cytochrome oxidase 2. c Annexin-V-FITC/propidium iodide staining 2h after addition of glucose to cells grown on galactose. Green
colored ﬂuorescence originates from annexin staining, red colored ﬂuorescence represents propidium iodide binding to DNA of death cells. The scale bar is
250 μm. d Reactive oxygen species (ROS) accumulation 2 h after addition of glucose to cells grown on galactose. ROS was stained with the dye
dihydrorhodamine 123. DIC, differential interference contrast image. The scale bar is 125 μm
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that in a strain expressing the constitutively active Ras2val19
oncogene equivalent (Fig. 2a). A Ras2val19 strain, however, has no
detectable growth inhibition on glucose medium10. Deletion of
hexokinase 2 abolishes glucose-induced hyperactivation of Ras
(Fig. 2a), which is consistent with its complete suppression of the
glucose growth defect of the tps1Δ strain30. Whereas the Ras2val19
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Fig. 3 Restoration of growth on glucose and glycolytic metabolite levels in the tps1Δ strain with downregulation of the Ras-cAMP-PKA pathway. a Growth
of tps1Δ and suppressor strains on galactose and different concentrations of glucose. Five-fold dilutions were spotted. b Intracellular Glu6P, Fru1,6bisP and
ATP concentration before and after addition of 100mM glucose. The short-term measurements (0–10min) were performed with non-growing cells
incubated in 25mM MES buffer (pH 6.0), while the long-term measurements (0–30 h) were performed with cells growing in minimal galactose medium
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strain shows normal growth on glucose, it grows with strongly
reduced rate on poor carbon sources, like galactose, and dies in
stationary phase10. More recent work has shown that hyperactive
Ras causes programmed cell death/apoptosis in non-growing
yeast cells11. Hence, we reasoned that the combination of aber-
rant growth initiation due to the glycolytic deregulation and
hyperactivation of Ras in tps1Δ cells may cause apoptosis and
that this actually might be the real cause for the unusually high
glucose sensitivity of tps1Δ cells29 rather than the deregulation of
glycolysis per se. Determination of classical read-outs for
apoptosis in yeast gave results consistent with this hypothesis.
Glucose addition to tps1Δ cells, as opposed to wild type cells,
caused rapid release of cytochrome c from the mitochondria
(Fig. 2b), exposure of phosphatidylserine at the plasma mem-
brane (Fig. 2c) and generation of reactive oxygen species (ROS)
(Fig. 2d). These results are consistent with recent evidence that
the Tps1 protein acts as an anti-apoptotic factor in yeast31. The
drop in the cytochrome c level in the wild-type cells might be
caused by glucose repression of the CYC1 gene32. It is absent in
the tps1Δ strain because that strain is deﬁcient in glucose-induced
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Fig. 4 Activation of Ras by Fru1,6bisP. a Ras-GTP level 3 min after addition of 5 mM of different glycolytic metabolites to permeabilized yeast spheroplasts.
Glu6P, glucose-6-phosphate; Tre6P, trehalose-6-phosphate; Fru6P, fructose-6-phosphate; Fru1,6bisP, fructose-1,6-bisphosphate; DHAP, dihydroxyacetone
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Ras level compared to the ratio for the water control set at 1.0. The values were determined through quantiﬁcation by densitometry and are expressed as
relative arbitrary units. b Activation of Ras in permeabilized spheroplasts with different concentrations of GTP, Fru1,6bisP, DHAP and GAP. Quantiﬁcation
of the signals as Ras-GTP level/total Ras level compared to the ratio for the water control set at 1.0. The values were determined through quantiﬁcation by
densitometry and are expressed as relative arbitrary units. c Ras-GTP level before and 10 min after addition of 100 mM glucose (glu) to cells grown on
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values were determined through quantiﬁcation by densitometry and are expressed as relative arbitrary units. d Intracellular ATP, Glu6P, and Fru1,6bisP
concentration before and after addition of 100 mM glucose to cells grown in glycerol +2.5 mM glucose
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signaling28. The inability to detect a decrease in the cytochrome c
content of the mitochondria in the tps1Δ strain concomitant with
the appearance of cytochrome c in the supernatant, is likely due
to the fact that the amount appearing in the supernatant is much
smaller than the amount remaining in the mitochondria.
Deletion of Ras2 in the tps1Δ strain caused partial recovery of
growth on glucose (Fig. 3a). Overexpression of PDE2, which
encodes the high-afﬁnity cAMP phosphodiesterase and is known
to counteract phenotypes caused by hyperactive Ras33, restored
growth on glucose even better (on solid medium: Fig. 3a; in liquid
medium: Supplementary Fig. 1). This may be due to the fact that
overexpression of Pde2 lowers the cAMP level in the cells even
more than deletion of Ras2 and thus leads to lower PKA activity.
Our results are consistent with overactive Ras playing a role in the
glucose growth defect of the tps1Δ strain. Interestingly, both in
the tps1Δ and tps1Δ ras2Δ strain a very similar deregulation of
glycolysis after addition of glucose was present, including
hyperaccumulation of Fru1,6bisP and depletion of ATP, but the
metabolite proﬁle started to recover in the tps1Δ ras2Δ strain
after about 5 h to ﬁnally reach the same proﬁle as observed in
wild type cells (Fig. 3b). The difference was most striking in the
ATP level, which stayed close to zero in the tps1Δ strain, but
recovered to the same level as in wild type cells in the tps1Δ
ras2Δ and tps1Δ pPDE2 strains (Fig. 3b). This indicates
remarkable robustness and ﬂexibility of the glycolytic pathway
in yeast and contradicts that the strong perturbation of metabolite
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homeostasis is causing the glucose growth defect. The results
suggest that the induction of programmed cell death, caused by
overactivation of the Ras-cAMP-PKA pathway, is the true cause
of the inability of the tps1Δ strain to grow on glucose, rather than
the glycolytic deregulation, which is usually thought to be the
main cause34. The onset of the normalization of glycolytic
metabolite homeostasis a few hours after addition of glucose in
the tps1Δ ras2Δ and tps1Δ pPDE2 strains (Fig. 3b) might suggest
that an additional time-dependent change in initial glucose
catabolism occurs, which allows the cells to recover normal
glycolytic ﬂux and intermediate levels.
Fru1,6bisP triggers activation of Ras. To investigate whether
one or more of the hyperaccumulated glycolytic metabolites in
the tps1Δ strain acted as the trigger for hyperactivation of Ras, we
made use of nystatin-permeabilized wild type yeast
spheroplasts35. These are cells of which the cell wall has been
largely removed and the plasma membranes permeabilized to
allow passage of all small molecules. Because of their fragility the
permeabilized cell sacs were not washed and the small molecules
leaked into the medium were thus only strongly diluted. Addition
of glycolytic metabolites to permeabilized spheroplasts revealed
strong activation of Ras by Fru1,6bisP at the higher physiological
concentrations (4–8 mM; Fig. 4a, b), similar to that observed with
physiological concentrations of GTP (Fig. 4b). DHAP and GAP
also caused activation but only in unphysiologically high con-
centrations (1–5 mM; Fig. 4a, b). Other glycolytic
intermediates, and glucose or Tre6P did not cause activation
(Fig. 4a).
To evaluate whether Fru1,6bisP is responsible for glucose-
induced hyperactivation of Ras in the tps1Δ strain, we
constructed tps1Δ strains with additional single or double
deletion of the PFK1 and PFK2 genes, encoding phosphofructo-
kinase 1. Glucose-induced activation of Ras was reduced in cells
of the tps1Δ pfk1Δ and tps1Δ pfk2Δ strains, and abolished in cells
of the tps1Δ pfk1Δ pfk2Δ strain (Fig. 4c). This would be
consistent with the hyperaccumulation of Fru1,6bisP in tps1Δ
cells being responsible for hyperactivation of Ras. However, upon
measurement of the glycolytic metabolites, the tps1Δ pfk1Δ and
tps1Δ pfk2Δ strains were already deﬁcient in glucose-induced
hyperaccumulation of Fru1,6bisP and consistently showed a
much higher accumulation of Glu6P than the tps1Δ strain
(Fig. 4d). Glu6P was also higher than in the corresponding pfk1Δ
and pfk2Δ strains (Fig. 4d).
The presence of partial Ras activation without Fru1,6bisP
accumulation in the tps1Δ pfk1Δ and tps1Δ pfk2Δ strains
suggests that there may be a second mechanism responsible for
glucose-induced hyperactivation of Ras in the tps1Δ strain and/or
that the hyperaccumulation of Glu6P in these strains in some way
triggers a residual activation. Although the complete absence of
Ras hyperactivation in the tps1Δ pfk1Δ pfk2Δ strain seems to
contradict this possibility, the very poor growth of this strain,
requiring feeding with both a respiratory carbon source and a low
level of glucose, may have compromised the second activation
mechanism. It can also not be excluded that one of the glucose
signaling pathways modiﬁes Cdc25, for instance through
phosphorylation, to render it more sensitive to Fru1,6bisP. This
could explain why even in the absence of an increase in the level
of Fru1,6bisP, it would still be able to trigger activation of Ras
after addition of glucose.
Fru1,6bisP acts through the Ras GEF Cdc25 in yeast. We next
investigated whether Fru1,6bisP caused direct activation of Ras or
acted through one of its regulators, the guanine nucleotide
exchange proteins Cdc25 and Sdc25, or the GTPase activating
proteins Ira1 and Ira2. For that purpose we constructed several
strains with combinations of tps1Δ and deletions in the genes
encoding these regulators. Deletion of both CDC25 and SDC25 is
lethal36, while deletion of IRA1 and IRA2 causes hyperactivation
of Ras37. The ira1Δ ira2Δ cdc25Δ sdc25Δ strain retains enough
Ras activity for growth (Fig. 5a). All quadruple tps1Δ strains with
at least one wild-type GEF factor, Cdc25, or Sdc25, were unable to
grow on glucose, whereas absence of both GEF factors in the
quintuple deletion strain tps1Δ cdc25Δ sdc25Δ ira1Δ ira2Δ
restored to some extent growth on glucose medium (Fig. 5a,
Supplementary Fig. 2). This suggests that glucose-induced
hyperactivation of Ras through the GEF factors is a major
cause of the glucose sensitivity of the tps1Δ strain. The tps1Δ
ira1Δ ira2Δ strain showed already a high Ras-GTP level on
galactose medium, which made it difﬁcult to evaluate any further
glucose-induced increase (Fig. 5b). On the other hand, in the
quadruple deletion strains, tps1Δ sdc25Δ ira1Δ ira2Δ and tps1Δ
cdc25Δ ira1Δ ira2Δ, the rapid glucose-induced hyperactivation
of Ras was largely abolished, indicating requirement of both GEF
factors. The absence of Ras hyperactivation in these strains may
be restricted to the short-term response, since both strains were
still unable to grow on glucose (Fig. 5a). Unexpectedly, we found
that the quintuple deletion strain, tps1Δ cdc25Δ sdc25Δ ira1Δ
ira2Δ, showed a higher basal activity of Ras on galactose medium,
which, however, did not increase further upon addition of glucose
(Fig. 5b). Although these experiments and the interpretation of
the results are complicated because of the essential character of
the GEF factors, the high basal Ras activity caused by deletion of
the GAP proteins, and the unexpectedly higher basal level of Ras-
GTP in the quintuple deletion strain, the results are consistent
with a role of the GEF factors in mediating glucose-induced
hyperactivation of Ras in the tps1Δ strain. This was conﬁrmed by
the observation that deletion of SDC25 and especially CDC25 in
the tps1Δ strain caused partial growth recovery on glucose
(Supplementary Fig. 3). This result also suggests that Fru1,6bisP
exerts its activating effect mainly through Cdc25.
We have also performed similar experiments in the wild-type
strain background. This conﬁrmed the much weaker and more
variable glucose-induced activation of Ras in the wild type strain
(which may be due to transient oscillation in the response;
Fig. 5c). Deletion of IRA1 and IRA2 caused a dramatic increase in
Ras-GTP both in galactose and glucose incubated cells (Fig. 5c),
which made it impossible to evaluate reliably any possible further
increase in Ras-GTP in the presence of glucose. Deletion of
CDC25 or SDC25 caused a partial reduction of the very high Ras-
GTP level, while double deletion of CDC25 and SDC25 caused a
further reduction in the Ras-GTP level (Fig. 5c). In none of the
latter strains was a signiﬁcant difference between the galactose
and glucose condition observed, consistent with the idea that the
glucose activation effect on Ras acts through its Cdc25 and Sdc25
GEF factors.
Since previous work had shown that the highly conserved C
terminus of Cdc25 was required for glucose activation of cAMP
synthesis38, 39, we focused on this part of Cdc25 to identify amino
acid residues of which mutagenesis might abolish Fru1,6bisP
activation of Ras in permeabilized spheroplasts and also restore
growth of the tps1Δ mutant on glucose. We selected for
site-directed mutagenesis a highly conserved region with several
positively charged residues (Fig. 6a) (aa 1478–1501 in Cdc25) that
could possibly be involved in the formation of a binding site for
the negatively charged Fru1,6bisP molecule. Interestingly, another
positively charged residue, R1122 in yeast Cdc25, which
corresponds to K602 in human Sos1, resides in the vicinity of
this region in the 3D structure of the human Sos1 catalytic
domain40. The R1122/K602 residue is located itself in a small
conserved region. Figure 6a shows the 3D structure of Sos1 in
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association with Ras and the position in space of selected amino
acid residues in the cleft formed by the alpha helix I of Sos1 and
the switch 1 region of Ras, thus in the area where the two proteins
interact. The amino acid residues K602, R962, and K963 of Sos1,
are located within this cleft (Fig. 6a).
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Fig. 6 Conserved residues in the C terminus of Cdc25 and Sos1 are required for Fru1,6bisP activation of Ras. a Alignment of the conserved region in the Ras
GEF factors, HsSos1 and HsSos2 from Homo sapiens and ScCdc25 and ScSdc25 from Saccharomyces cerevisiae. Crystal structure of the complex between
human Sos1 (green) and human Ras (purple) (PD entry: 1BKD40). The arrow points to the cleft, which contains the conserved region. Enlarged view on the
3D structure surrounding the relevant residues in Sos1 and Cdc25 located in the conserved region. b, d Ras-GTP level 3 min after addition of 5 mM
Fru1,6bisP or 1 mM GTP as positive control, to permeabilized yeast spheroplasts from strains expressing mutant ScCdc25 (b) or HsSos1 (d) alleles.
Western blots were quantiﬁed and the Ras-GTP levels are shown relative to the level observed after addition of GTP. Values represent average (number of
replicates shown above each graph), error bars represent standard deviations. Sidak’s multiple comparison test was used for evaluation of statistical
signiﬁcance ((NS) identiﬁes p-values greater than 0.05, (*) identiﬁes p-values between 0.01 and 0.05, (**) between 0.01 and 0.001, (***) between 0.001
and 0.0001, (****) identiﬁes p-values lower than 0.0001). c Recovery of growth on glucose in the tps1Δ sdc25Δ strain expressing Cdc25R1122D,K1491E
instead of wild type Cdc25
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We ﬁrst mutagenized the positively charged residues R1122
and K1491 in Cdc25 to negatively charged aspartate and
glutamate residues, respectively. In addition, we constructed the
T1490P allele of Cdc25 in order to disturb the structure of the
alpha helix39 in this region. In permeabilized spheroplasts of
strains expressing Cdc25R1122D,K1491E or Cdc25T1490P instead of
wild-type Cdc25, addition of Fru1,6bisP in a physiological
concentration of 5 mM no longer caused activation of Ras as
opposed to addition of GTP (Fig. 6b). This indicates that the
residues R1122 and K1491 are in some way important for
Fru1,6bisP activation of Ras, either because of direct interaction
with Fru1,6bisP or maintenance of a proper Cdc25 conformation,
and that also the structure of the alpha helix surrounding T1490
is important for a similar reason.
The activity of Sdc25 was assumed negligible since it is
repressed during exponential growth in rich media36. The strains
carrying the Cdc25 mutated alleles in the absence of Sdc25 were
viable, showing that the alleles were functional. Interestingly, a
tps1Δ sdc25Δ strain expressing Cdc25R1122D,K1491E instead of
wild-type Cdc25 displayed strong recovery of growth on glucose,
supporting the requirement of these residues for Fru1,6bisP
activation of Ras in vivo (Fig. 6c). We did not observe such
recovery of growth on glucose with a strain expressing
Cdc25T1490P instead of wild-type Cdc25 (Supplementary Fig. 4a).
However, such a strain displayed reduced trehalose and glycogen
levels, suggesting the presence of constitutively activated PKA
(Supplementary Fig. 4b). This may be explained by Thr1490
serving as a PKA target site for feedback inhibition of PKA on
Cdc25, as previously suggested39 or may be due to another effect
caused by the distortion of the alfa-helix structure.
Next, we assessed whether human Sos1 expressed in yeast is
also responsive to the same type of glycolytic stimulation as yeast
Cdc25. Interestingly, addition of Fru1,6bisP in a physiological
concentration of 5 mM to permeabilized yeast spheroplasts
expressing only the guanine nucleotide exchange factor region
of human Sos1 (residues 553–1024), caused a clear activation of
Ras similar to that of GTP (Fig. 6d). Wild type Sos1 has the
INFSKRR962K sequence. However, the yeast strain expressing
the complete Sos1 protein grew poorly on galactose. The mutant
protein R962T, which has the same INFSKRTK sequence as in
Cdc25, also supported activation of Ras with Fru1,6bisP and GTP
(Fig. 6d). The strain expressing this protein showed normal
growth on galactose, consistent with the threonine being a target
of PKA feedback inhibition. Activation of Ras in permeabilized
spheroplasts with Fru1,6bisP, but not GTP, was absent for the
mutant alleles Sos1K602E, K963E and Sos1R962P (Fig. 6d), which
have the equivalent mutations to those mentioned above for yeast
Cdc2540. The single-mutation K963E did not yet abolish
Fru1,6bisP activation of Ras. These results show that Sos1 is able
to mediate activation of Ras by Fru1,6bisP and that the
corresponding amino acid residues or combinations to those in
Cdc25 are also important for the activation.
There are several possibilities for the mechanism by which
interaction of Fru1,6bisP with Cdc25/Sos1 might stimulate
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Fig. 7 Fru1,6bisP binds to Sos1 and disrupts the Sos1/H-Ras complex. a, Biolayer interferometry (BLI) measurements showing the disruption of the
Sos1/H-Ras complex. His-tagged H-Ras was coupled to Ni2+-coated biosensors and loaded with 0.5 µM of non-tagged Sos1 (association phase).
Subsequently, dissociation of Sos1 was monitored in buffer containing increasing concentrations of Fru1,6bisP (0, 2, 5, 10, 20, 50, and 100 mM as labeled
on the curves). The rates of Sos1 dissociation are dependent on the Fru1,6bisP concentration. b Titration curve showing the inﬂuence of Fru1,6bisP
concentration on Sos1/H-Ras complex dissociation. Plotting the BLI signal amplitude as shown in panel a after 150 s of complex dissociation (R; mean± s.
d.; n= 3 independent experiments) vs. the Fru1,6bisP concentration yields a binding curve that was ﬁtted on a Langmuir binding model to obtain an
apparent KD (KDapp) value (±s.e.). c Titration curves for binding of Fru1,6bisP to either Sos1 or H-Ras. Melting temperatures (Tm) of Sos1 and H-Ras at
different ligand concentrations were obtained via thermal shift assays (n= 3 independent experiments). Plotting Tm values (mean± s.d.) vs. ligand
concentration yielded binding curves that were ﬁtted on a Langmuir binding model to obtain KD values (±s.e.)
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activation of Ras. It might alleviate one of the limiting steps in the
Cdc25/Sos1-Ras nucleotide exchange cycle, for instance the
binding of Ras to Cdc25/Sos1, the release of GDP, the
incorporation of GTP, the dissociation of Cdc25/Sos1 from Ras
or the shielding of Ras from the action of the GTPase activating
proteins Ira1,2/NF1.
Fru1,6bisP stimulates dissociation of the Ras/Sos1 complex. To
study the interaction of Fru1,6bisP with Ras and its Ras GEF
factor, we performed an in vitro binding assay (Octet Biolayer
interferometry) using human H-Ras (residues 1–166) and the
catalytic part of Sos1 (residues 564–1049), and analyzed the effect
of Fru1,6bisP on the stability of the Ras/Sos1 complex. First,
H-Ras molecules were loaded onto the biosensor, and Sos1
molecules were allowed to bind to H-Ras during the association
phase. Next, the dissociation of the H-Ras/Sos1 complex was
monitored in the presence of increasing concentrations of
Fru1,6bisP. The biolayer interferometry measurements showed
that Fru1,6bisP increases the dissociation rate of the H-Ras/Sos1
complex in a dose-dependent way (Fig. 7a). Plotting of the
response (taken 150 s after addition of Fru1,6bisP) vs. the
Fru1,6bisP concentration and ﬁtting yields an apparent KD
(KDapp) of 9.3± 0.3 mM (Fig. 7b), which is in accordance with
physiological concentrations of Fru1,6bisP in both mammalian
and S. cerevisiae cells41–43. As a control we also tested the effect of
addition of glucose, Fru6P, DHAP and GAP. Glucose had no
effect on the H-Ras/Sos1 complex, while Fru6P and DHAP
produced a very small effect at non-physiological concentrations
(KDapp= 96± 40 mM and KDapp= 120± 41 mM for Fru6P and
DHAP, respectively; Supplementary Fig. 11). Addition of GAP
had no effect on the Ras/Sos1 complex up to a concentration of 2
mM, but it led to a very fast decrease in signal due to unspeciﬁc
dissociation of H-Ras from the biosensor at higher
concentrations.
We also performed additional biolayer interferometry (BLI)
measurements monitoring the disruption of the Sos1/H-Ras
complex by different intermediates of glycolysis and GTP
(Supplementary Fig. 11). This showed that only Fru1,6bisP and
to a lesser extent Fru6P enhanced the rate of Sos1 dissociation.
Fru1,6bisP directly binds to human Sos1. To ﬁnd out whether
the observed disruption of the H-Ras/Sos1 complex is due to
direct binding of Fru1,6bisP to either H-Ras or Sos1, we deter-
mined the thermal stability (melting temperature, Tm) of both
proteins in the presence of increasing amounts of Fru1,6bisP,
using thermal shift assays44. While the thermal stability of H-Ras
was quasi unaffected by addition of Fru1,6bisP, the thermal sta-
bility of Sos1 increased in the presence of Fru1,6bisP in a
dose-dependent way indicating direct binding of Fru1,6bisP to
Sos1 (Fig. 7c). Fitting the Tm value vs. the Fru1,6bisP
concentration on a Langmuir-binding model yielded a KD of
17.5± 2.2 mM. It should be noted that the latter KD value cor-
responds to the real thermodynamic KD for binding of Fru1,6bisP
to Sos1, while the KDapp for dissociation of the H-Ras/Sos1
complex also depends on kinetic parameters (rate of complex
dissociation).
Glucose activates Ras/MEK/ERK pathway in human cell lines.
To assess whether the observed effect of Fru1,6bisP retains phy-
siological relevance in human cells, we studied Ras, MEK, and
ERK activation after the addition of glucose to glucose-starved
HEK293T and Hela Kyoto cell lines. A 48 h glucose starvation
period lowers the glycolytic ﬂux drastically and thus also the
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Fig. 8 Addition of glucose triggers activation of the Ras/MEK/ERK pathway in glucose-starved human HEK293T and Hela Kyoto cells. a Western blot
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Fru1,6bisP level41. Re-addition of glucose is known to elevate the
intracellular concentration of Fru1,6bisP when glycolysis starts
up. The results showed that glucose addition transiently activates
Ras, as well as its downstream targets MEK and ERK, both in
regular human cells and in cancer cells (Fig. 8a). The ratio of Ras-
GTP over total Ras was quantiﬁed for better interpretation
(Fig. 8b).
Absence of correlation with proliferation rate. We have also
performed multiple experiments to evaluate whether there might
be a direct relationship between the proliferation rate of yeast
cells, the concentration of Fru1,6bisP and the Ras-GTP level.
First, we have measured these three parameters using a series of
carbon sources sustaining different proliferation rates. Although
there was a tendency for the Ras-GTP level to be lower with lower
growth rate, it was certainly not in proportion with the drastically
reduced Fru1,6bisP level during growth on non-fermentable
carbon sources compared to growth on fermentable sugars
(Supplementary Fig. 5). Next, we starved yeast cells for nitrogen
on a glucose-containing medium for 50 h and then re-initiated
growth by adding a nitrogen source again. This resulted in a
drastic drop in Fru1,6bisP and rapid recovery, respectively.
However, there was no concomitant change in the level of
Ras-GTP at all in the two conditions (Supplementary Fig. 6). We
made also use of a yeast strain lacking the PFK26 and PFK27
genes, which encode phosphofructokinase 245. It is responsible
for the synthesis of Fru2,6bisP, a potent allosteric activator of
phosphofructokinase 1. The double-deletion strain had a strongly
reduced level of Fru1,6bisP and a slight reduction in growth rate.
However, its Ras-GTP level remained unchanged (Supplementary
Fig. 7). Next, we investigated whether the slight reduction in
growth rate of the pfk26Δ pfk27Δ strain could be suppressed by
an increase in the activity of Ras. The latter was accomplished by
single or double deletion of the IRA1 and IRA2 genes37 (Sup-
plementary Fig. 8) or by expression of RAS2val19 [10] (Supple-
mentary Fig. 9). However, in none of the two cases was there any
increase in the growth rate, neither on glucose nor on galactose
medium. All these results indicate that there is no direct rela-
tionship between the Fru1,6bisP level and the Ras-GTP level in
yeast cells with different proliferation rates. The absence of a clear
correlation between Fru1,6bisP and Ras-GTP levels implies that
other mechanisms, such as regulation of Ira1,2 activity, must also
control the Ras-GTP level. Since yeast strains with constitutively
high-Ras activity always showed a tendency for slower growth
rates, we overexpressed RAS2val19 with a multi-copy vector in
different yeast strains. In all cases this led to a dramatic reduction
in growth rate on glucose medium (Supplementary Fig. 10). This
shows that RAS2val19 is not only toxic under poor growth con-
ditions and in stationary phase, but that very-high expression is
also toxic under optimal growth conditions for yeast.
Discussion
It has been reported that Ras activation stimulates glycolytic rate
in tumor cells46, 47. The opposite signaling effect that we describe
here, i.e., activation of Ras by high glycolytic rate through
Fru1,6bisP, may close a reciprocal stimulatory signaling loop
between cell proliferation and glycolysis. In this regard, increased
cytosolic concentrations of Fru1,6bisP have been found in cancer
cells42, 43. Moreover, occurrence of mitochondrial dysfunction,
accumulation of ROS and switch from respiration to increased
glycolytic activity has also been observed in a mammalian cell
system in which the K-Ras(G12V) oncogene was expressed from
an inducible promoter48. Hence, the reciprocal activation
between glycolytic ﬂux and Ras may lock cancer cells in a vicious
cycle causing both persistent stimulation of cell proliferation and
continued maintenance of overactive glycolysis. This would
explain the close correlation between the proliferation rate and
aggressive character of cancer cells and their fermentation
hyperactivity3, 4, 49. The new regulatory mechanism is consistent
with the synthesis of Fru1,6bisP by phosphofructokinase being a
major target of metabolic control pathways, oncogene products
and tumor suppressor genes in mammalian cells22, 46, 47. It also
explains the observation that fructose-1,6-bisphosphatase coun-
teracts carcinoma progression50 and that nucleophosmin (NPM1)
promotes tumor progression by inhibiting fructose-1,6-bispho-
sphatase51. The similarity between yeast and mammalian cells is
further underscored by the ﬁnding that in both systems translo-
cation of activated Ras to the mitochondria results in loss of
respiratory activity and the appearance of apoptotic markers48, 52.
Our results show that neither metabolic deregulation, as
observed in the tps1Δ strain with ras2Δ or pPDE2 suppressors,
nor the presence of hyperactive Ras, as in a yeast strain expressing
Ras2val19, is by itself enough to trigger apoptosis and absence of
growth on glucose. It is apparently the combined presence of
metabolic deregulation, or stalled metabolism, and hyperactive
Ras that forces the cells into the pathway of programmed cell
death. Similar observations have been made with cancer cells in
which glucose deprivation triggers apoptosis47 and vitamin
C treatment kills RAS-oncogene expressing tumor cells, but not
wild-type RAS containing cells, by inhibition of GAPDH53.
Combined hyperactivation of Ras and inhibition of glycolysis at
the level of GAPDH is also observed in the yeast tps1Δmutant, in
which it is responsible for induction of apoptosis. This combined
requirement may help to explain why RAS oncogenes trigger
apoptosis only under speciﬁc conditions which lead to metabolic
deregulation. Another similar mechanism has recently been
reported in which Fru1,6bisP directly binds and activates epi-
dermal growth factor receptor (EGFR) causing increased lactate
excretion, and EGF signaling activates glycolysis upstream while
inhibiting downstream, causing accumulation of intermediates
like Fru1,6bisP54.
The Biolayer interferometry (BLI) measurements clearly indi-
cate that Fru1,6bisP increases the rate of dissociation of the
nucleotide-free Ras-SOS complex. This was unexpected in view of
the activating effect of Fru1,6bisP on Ras. Moreover, our results
also show that Fru1,6bisP directly binds to SOS1 (and not to Ras).
From our results it is hard to pinpoint how exactly this leads to
increased activation of Ras in the complex surroundings of the
cell. However, it is known that activation of Ras by SOS normally
occurs in two steps, where in a ﬁrst step binding of SOS to GDP-
bound Ras leads to dissociation of GDP and in a second step
binding of GTP to the nucleotide-free Ras-SOS complex leads to
dissociation of the complex concomitant with Ras-GTP loading40.
Increased activation of Ras in a cellular context could potentially
occur through increasing the rate of either step. The observed
Fru1,6-bisP-induced dissociation of the nucleotide-free Sos–Ras
complex might accelerate activation of Ras by acting between
these two steps or through another yet to be identiﬁed mechan-
ism. Moreover, at least in yeast, the number of Cdc25 molecules is
very low compared to the number of Ras molecules55. Hence, a
second way in which faster dissociation of Cdc25 and Ras may
stimulate Ras activity, is that it may make the limited number of
Cdc25 molecules more rapidly available for activation of other
Ras molecules.
Since Fru1,6bisP is able to chelate Mg2+56, we have considered
the possibility that a reduction in the Mg2+ concentration may
activate nucleotide exchange on Ras. However, the effect of
Fru1,6bisP in the in vitro biophysical experiments is already
observed at concentrations much lower than the 10 mM MgCl2
used in the buffer. Also the direct binding of Fru1,6bisP on SOS
with a KD in the same range as the Fru1,6bisP concentration
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in vivo and the apparent KD for Ras-SOS complex dissociation
argues against a mere effect of Fru1,6bisP as a chelator.
We have also performed multiple experiments to evaluate
whether there might be a direct relationship between the pro-
liferation rate of yeast cells, the concentration of Fru1,6bisP and
the Ras-GTP level. However, no clear correlation could be found
(see Supplementary Figs. 5–10). Hence, although both yeast and
mammalian cells show within min rapid glucose-induced acti-
vation of Ras and its downstream targets, other mechanisms may
intervene in hierarchical control of the cell proliferation rate.
In conclusion, we have identiﬁed a direct regulatory connection
between Fru1,6bisP in glycolysis and the Ras proteins, that seems
to be evolutionary conserved in yeast and mammalian cells. It is
responsible for induction of apoptosis in yeast cells with over-
active inﬂux of glucose into glycolysis and stalled ﬂux at the level
of GAPDH. We suggest that Fru1,6bisP activation of Ras con-
stitutes a key mechanism through which the Warburg effect
might stimulate oncogenic potency.
Methods
Yeast strains and plasmids. All S. cerevisiae strains used in this work are listed in
Supplementary Table 1. They all share the same genetic background, i.e. W303.
The YEplac195 expression vector contains the promoter and terminator sequences
of the 5′ and 3′ regions of the PDE2 gene. The YCpRas2val19 plasmid contains
promoter and terminator sequences of the 5′ and 3′ regions of the RAS2val19 gene.
Growth conditions. When no selection was required, yeast cells were grown in rich
YP (1% (w/v) yeast extract, 2% (w/v) bactopeptone) medium, supplemented with
100 mg/L adenine and either 100 mM glucose, 100 mM galactose, 220 mM ethanol
or 325 mM glycerol. In case of selection for the presence of an auxotrophic marker
either on a plasmid or in the genome, cells were grown in synthetic medium
containing 0.17% (w/v) yeast nitrogen base without amino acids, 0.5% (w/v)
ammonium sulfate, the appropriate amount of the required synthetic ‘drop out’
amino acid and nucleotide mixture and supplemented with 100 mM glucose, 100
mM galactose, 220 mM ethanol or 325 mM glycerol. The pH was adjusted with 4 M
KOH to 5.5 for liquid medium and 6.5 for solid medium. For solid medium, 1.75%
(w/v) agar was added after pH adjustment. Strains were grown at 30 °C. Liquid
cultures were grown under continuous shaking (180 r.p.m.).
Expression and puriﬁcation of RBD-GST from Escherichia coli. Ras-binding
domain of the Raf1-kinase (RBD) GST-fusion protein was constructed in the
pGEX2T-1 expression vector and expressed in the E. coli BL21 strain. Cells were
grown for 1 h at 37 °C prior to addition of IPTG to a ﬁnal concentration of 0.3 mM
to induce gene expression from the pGEX2T-1 plasmid. Induction lasted for 3 h at
30 °C. Cells were harvested and washed with ice-cold PBS buffer. Cells were
resuspended in 5 mL per L culture lysis buffer containing 50 mM Tris-HCl pH 7.5,
50 mM NaCl, 2 mM EDTA pH 8, 1 mM EGTA pH 8, 20% sucrose and 5 mg/mL
lysozyme at a concentration of 10 mL per L of culture and incubated for at least 15
min. 3 volumes of ice-cold buffer containing 50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1% Triton X-100 and protease inhibitor cocktail (complete, EDTA-free,
Roche) was added. Cells were lysed by sonicating three times for 15 s. Lysates were
clariﬁed by centrifugation at 20,000 r.p.m. for 25 min at 12,000 × g. The resulting
supernatant fraction was incubated with 2 mL per L of initial culture of a
50–50 slurry of glutathione-sepharose beads (GE Healthcare) prewashed with 1 x
TBST (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100 and 1 mM DTT)
and incubated for 1 h in a roller drum at 4 °C. Beads were collected by cen-
trifugation at 1800 rpm for 1 min and washed 4 times with TBST. Beads were
resuspended in TBS (TBST minus Triton) at a ﬁnal concentration of 10%. The
addition of 0.02% NaN3 allowed keeping this solution for up to 6 months.
Preparation of a yeast crude cell extract. Cells were grown to an OD of 3–4 and
collected on a microﬁlter connected to a vacuum pump. After washing with ice-
cold water, 200 mg cells were collected in a screw cap tube. 0.2 g of glass beads were
added together with 500 µL of lysis buffer containing 50 mM Tris-HCl pH 7.5, 10%
glycerol, 2.5 mM MgCl2, 1% Igepal (NP-40) and 200 mM NaCl. The cells were
broken by shaking three times 20 s in a fast prep apparatus. A clariﬁed crude
protein extract was obtained after 5 min centrifugation at 8000 rpm. Protein con-
centration was measured by mixing 20 µL of sample together with 300 µL of the
Pierce 660 nm protein measurement buffer and absorbance was measured at 660
nm using a bovine serum albumin (BSA) standard curve.
Preparation of permeabilized spheroplasts. The protocol for preparation of
spheroplasts was adapted from previous reports35, 57. Strains were grown in 1 L YP
galactose to exponential phase (OD600= 2). The cells were washed with water and
resuspended at a concentration of 200 mg/mL in digestion buffer containing 1.2 M
sorbitol, 60 mM potassium phosphate buffer pH 7.5 (K2HPO4 + KH2PO4), 1 mM
EDTA pH 8, 10 µL/mL β-mercaptoethanol and 100 units/mL lyticase. This cell
suspension was incubated at 30 °C and digestion of the cell walls was followed by
the decrease in OD600 for a sample of the spheroplast suspension was treated with
5% SDS (10 µL spheroplast suspension + 990 µL SDS). When OD600 had dropped
with 80% in this assay, the spheroplasts were considered appropriate for use and
the lyticase digestion was arrested by addition of four volumes of ice-cold 1.2 M
sorbitol solution. Spheroplasts were washed two times with ice-cold 1.2 M sorbitol
and resuspended in spheroplast buffer containing 1.2 M sorbitol, 0.75 mM EDTA,
2 mM MgSO4, 1.8 mM NaCl and 10 mM potassium phosphate buffer pH 6.8. A
sample was taken of the spheroplast suspension to measure protein concentration.
For that purpose, 10 µL spheroplast suspension was diluted with 90 µL of water and
the spheroplasts homogenized by vortexing. Subsequently, 20 µL of the resulting
solution was mixed with 300 µL of the Pierce protein measurement buffer and the
protein concentration was determined by measuring OD at 660 nm. The spher-
oplasts were then diluted with spheroplast buffer to a protein concentration of 2
mg/mL. To permeabilize the spheroplasts, they were incubated for 10 min at
30 °C with 20 µL/mL nystatin.
Ras activation assay. Two different Ras activation assays were used. Ras activa-
tion was either studied in vivo upon addition of glucose to galactose-grown cells, or
in situ, upon addition of different glycolytic intermediates, which cannot be taken
up by intact cells, to permeabilized spheroplasts. The level of Ras-GTP was
determined with the RBD-GST pull-down assay, as described previously15. The
responses in the spheroplast preparations showed some quantitative variability,
which is likely due to the elaborate spheroplast preparation protocol, but quali-
tatively the responses were always comparable.
Ras activation as determined with samples taken in vivo. For the in vivo Ras
activation assay, glucose was added to galactose-grown cells and the cells were
incubated further for 10 min. Crude cell extracts were prepared and a volume
containing 2 mg of total protein was added to the beads bound to RBD-GST and
incubated for 1 h at 4 °C on a roller drum. After incubation, the beads were washed
three times with the lysis buffer used to make the crude extracts. After washing, the
beads were dried by removing all liquid with a narrow oriﬁce 30 g needle. To the
dried beads, 20 µL of 2× loading buffer was added. This buffer contains 100 mM
Tris-HCl pH 8, 20 mM β-mercaptoethanol, 4% SDS, 0.2% bromophenol-blue and
20% glycerol. This solution was boiled for 5 min at 96 °C. A volume with 20 µg of
total protein was used for the control in which the total Ras content was deter-
mined and an equal amount of 2× loading dye was added and boiled. The samples
were then ready for western blotting.
Ras activation in permeabilized spheroplasts (in situ). Glycolytic metabolites
and GDP were dissolved in H2O to a ﬁnal concentration of 100 mM, except gly-
ceraldehyde-3-phosphate, which was dissolved in a potassium phosphate buffer
(because it is only available as a very acidic liquid solution). GTP was dissolved in
H2O to a ﬁnal concentration of 20 mM. 50 µL of the stock solutions was added to 1
mL permeabilized spheroplasts to obtain a ﬁnal concentration of 5 mM for the
metabolites and GDP and a ﬁnal concentration of 1 mM for GTP. The spheroplasts
were incubated for 3 min at 30 °C and after incubation snap frozen in liquid
nitrogen. 330 µL of a 4× lysis buffer was added to the frozen spheroplasts.
Spheroplast lysis was achieved by simple vortexing and the supernatant was cleared
by centrifugation at 8000 rpm for 5 min. Crude extracts were incubated with the
RBD-GST beads and further processed as described in the previous section.
Glucose activation of Ras in mammalian and cancer cells. Mammalian
HEK293T cells (ATCC, USA) and Hela Kyoto cancer cells (a kind gift of Dr. D.
Gerlich58), characterized by Short Tandem Repeat proﬁling, were used at low
passage number (<15) immediately after receipt or after resuscitation from early
stocks. Mycoplasma contamination was checked bimonthly with Venor Gem
Classic kit (Minerva Biolabs). Both cell lines were grown in Dulbecco’s Modiﬁed
Eagle Medium (DMEM) medium without glucose (11966-025, Invitrogen) sup-
plemented with 2 mM glucose (Life Technologies), 20 mM galactose (Sigma), 6
mM L-glutamine (Sigma), 1 mM sodium pyruvate (Invitrogen), 10% Fetal Calf
Serum (FCS, GE Healthcare), 5 mM HEPES buffer (pH 7.2–7.5) (Thermo Fischer
Scientiﬁc), 100 units/mL penicillin (Sigma) and 100 mg/mL streptomycin (Sigma),
prior to a 48 h glucose starvation period in the same medium without glucose
supplementation. Activation of Ras, MEK and ERK was monitored in cells incu-
bated in DMEM medium without glucose (D5030, Sigma-Aldrich) after supple-
mentation with 20 mM glucose, 5 mM HEPES buffer (pH 7.2–7.5), 10% FCS, 100
units/mL penicillin and 100 mg/mL streptomycin, for different time periods (0.5,
2.5, 5, 10, 20 and 40 min). Before lysis, cells were washed with ice-cold PBS (Sigma)
and collected in lysis buffer (1% NP40, 50 mM Tris-HCl (pH 7.4), 150 mM NaCl,
0.5 mM EDTA, 5 mM MgCl2 and protease/phosphatase inhibitor cocktails
(Roche)). Lysates were centrifuged (14,000 × g, 15 min, 4 °C) and the supernatants
were prepared for western blot analysis. Active Ras-GTP levels were assessed fol-
lowing pull-down using RBD-GST-fusion protein beads (1 h, 4 °C) (see above).
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Western blotting. All samples were boiled for 5 min at 96 °C and brieﬂy cen-
trifuged before loading on the electrophoresis gel. Proteins were separated via
SDS-PAGE (NuPAGE 4–12% Bis-Tris gel, Invitrogen) in NuPAGE MOPS SDS
running buffer (Invitrogen) at a constant voltage of 150–200 V. After electrophor-
esis, proteins were transferred onto nitrocellulose membranes (HybondC extra, GE
Healthcare) by blotting for 60min at 400mA in blotting buffer (NuPAGE MOPS
SDS running buffer, with 20% (v/v) methanol). Aspeciﬁc antibody binding was
prevented by incubating the membrane in blocking buffer ((5% (w/v) BSA in TBS-
Tween buffer (25mM Tris-HCl pH 8, 150mM NaCl, 0.05% (v/v) Tween-20)) for
1 h at room temperature. Subsequently, the blots were incubated overnight at 4 °C in
blocking buffer with the appropriate antibody: yeast Ras2 (Sc-6759, Santa Cruz,
1:1000, goat pAb), Human Ras (anti-Pan-Ras, Calbiochem, OP40-100UG, 1:500,
mouse mAb), ERK (anti-p44/42 MAPK (ERK1/2), Cell Signaling Technology,
#9102, 1:1000, rabbit pAb), P-ERK (anti-phospho-p44/42 MAPK (ERK1/2) (T202/
Y204), Cell Signaling Technology, #9101S, 1:1000, rabbit pAb), MEK (anti-MEK1/2
(L38C12), Cell Signaling Technology, #4694, 1:1000, mouse mAb, P-MEK (anti-
phospho-MEK1/2 (S217/221) (41G9), Cell Signaling Technology, #9154S, 1:1000,
rabbit), Vinculin (anti-vinculin, Sigma-Aldrich, V9131, 1:10000, mouse mAb).
Subsequently, the blots were washed three times with TBS-Tween buffer and
incubated with the appropriate secondary antibody (Sc-2020, Santa Cruz) in TBS-
Tween. After washing three times with TBS-Tween, the membranes were incubated
with Supersignal chemiluminescence substrate (Pierce). Proteins were visualized by
exposure of the membrane in the LAS4000 mini digital system (Fujiﬁlm). Signals
were quantiﬁed with Aida software. Uncropped scans of key western blots presented
in the main ﬁgures are provided in Supplementary Fig. 12.
Metabolite determinations. The cells for the metabolite measurements were
obtained by culturing in Complete Synthetic medium with 100mM galactose to an
OD of 2–3. They were harvested by centrifugation and washed two times with 25
mM β-morpholinoethanesulfonic acid (MES) pH 6. After the last wash step, the cells
were collected on a ﬁlter and weighed. For short-term (up to 10min) measurement
of the intracellular concentration of metabolites, the cells were then suspended at a
concentration of 75mg wet weight/mL in 25mM MES buffer and incubated in a
waterbath at 30 °C. Samples were taken by quenching 2mL of cell suspension in 10
mL of 60% methanol at—40 °C59. For metabolite determination after glucose
addition, a ﬁnal concentration of 100mM glucose was added to the cells and samples
were taken as a function of time by taking 2.5mL cell suspension which was
quenched in ice-cold methanol. The cells were centrifuged at −20 °C, at 3000 rpm for
3min. The supernatant was removed completely by the use of a vacuum pump and
resuspended in 500 µL of 1M perchloric acid (HClO4). The cells were transferred to
a screw cap tube and broken with glass beads in the fast prep apparatus (two times
20 s at speed setting of 6). 500 µL of 1M HClO4 was added again and the mixture
spun down for 4min at 12,000 r.p.m., at 4 °C. 250 µL was mixed with 10 µL thymol
blue (25mg/100mL) and 50 µL of 5M K2CO3. The tubes were left open for at least
15min to make sure all CO2 was released. 200 µL was transferred to a new test tube
and mixed with 100 µL of 1M HCl and 10 µL of 2M Tris-HCl pH 7.5.
For long-term (up to 30 h) measurement of the intracellular concentration of
different metabolites, cells were also grown in Complete Synthetic medium with
100 mM galactose to an OD of 2–3, after which 100 mM glucose was added in the
cultures. Samples were taken as a function of time as described for the short-term
experiments. At the same times a sample with equal volume was collected by
ﬁltration to determine the cell dry weight.
Glucose-6-phosphate and ATP. 50 µL of the sample was mixed with 150 µL of
reaction buffer containing 100 mM Hepes pH 7.6, 0.8 mg/mL NADP and 10mM
MgCl2. To measure glucose-6-phosphate the enzyme glucose-6-phosphate dehy-
drogenase (G6PDH) was added in a concentration of 50 µg/mL. The NADPH
formed in this reaction was measured at a wavelength of 340 nm. The amount of
NADPH determined is directly proportional to the amount of glucose-6-phosphate
present in the sample. For ATP determination, hexokinase at a concentration of
100 µg/mL was added together with 0.5 mM glucose. Hexokinase will produce
glucose-6-phosphate with the glucose added and the ATP present in the sample
and the glucose-6-phosphate will be converted again by G6PDH with the gen-
eration of NADPH, that is measured and is directly proportional to the ATP
concentration present in the sample.
Fructose-1,6-bisphosphate. 50 µL of the sample was mixed with 150 µL of reac-
tion buffer containing 100 mM Hepes pH 7.6 and 0.3 mM NADH, 2.5 µg/mL
glyceraldehyde-3-phosphate dehydrogenase and 2.5 µg/mL triose phosphate iso-
merase. For measurement of fructose-1,6-bisphosphate, aldolase was added at a
concentration of 100 µg/mL and the consumption of NADH was measured at a
wavelength of 340 nm.
Reactive oxygen species. The production of reactive oxygen species (ROS) was
assessed using dihydrorhodamine 123 (DHR; Sigma-Aldrich) as described pre-
viously60. Cells were grown in YP galactose medium until mid exponential phase, a
sample was collected and 100 mM glucose was added after which a new sample was
taken. 5 µg/mL DHR was added to the cells and incubated for 2 h. ROS production
was visualized using ﬂuorescence microscopy (Axioplan 2 imaging, Zeiss).
Annexin staining of phosphatidylserine exposure. Cells were stained using the
Annexin-V-FLUOS Staining Kit (Roche) as described previously60. After growing
cells to mid exponential phase in YP galactose medium, 100 mM glucose was
added. After 16 h the cells were collected, washed with PBS buffer and centrifuged
for 5 min at 200 × g. Annexin-V-FLUOS labeling solution was prepared according
to the instructions of the manufacturer: 1 mL of incubation buffer and 20 µL of
Annexin-V-FLUOS labeling reagent and 10 µL of propidium iodide solution.
Washed cells were incubated in 100 µL of this labeling solution for 15 min after
which the cells were observed in the ﬂuorescence microscope. Annexin-V-FLUOS
excitation was performed at 488 nm and emission was measured at 518 nm. Pro-
pidium iodide excitation was performed at 488–540 nm and emission was mea-
sured at 617 nm.
Isolation of mitochondria for cytochrome c release. The procedure was adapted
from a previous report61. A 1 L culture was used for each sample. 100 mM glucose
was added to a 1 L culture after which the culture was incubated for the indicated
time. The cells were harvested by centrifugation at 3000 rpm for 10 min and
washed two times with 1.2 M sorbitol. The cells were then resuspended in 5 mL of
digestion buffer per g cells. The digestion buffer contained 1.2 M sorbitol, 60 mM
potassium phosphate buffer pH 7.5, 1 mM EDTA pH 8, 1% β-mercaptoethanol
(w/v) and 1% zymolyase 20 T. The mixture was incubated for 1 h at 30 °C. The
spheroplasts formed were collected by centrifugation for 5 min at 1500 × g, washed
two additional times with 1.2 M sorbitol and resuspended in 3 mL of ST-Buffer,
containing 0.25 M sorbitol, 20 mM Tris-HCl pH 7.5, 1 mM EDTA and protease
inhibitor cocktail (Roche), per g of cells. The suspension was incubated with agi-
tation at 4 °C until the spheroplasts were osmotically broken. Cell debris were
removed by centrifugation at 2000 × g for 5 min and the supernatant was again
centrifuged at 12,000 × g for 15 min to precipitate mitochondria. Both the post-
mitochondrial supernatant (SN) and the pellet (the mitochondrial pellet was
resuspended in 0.5 M sorbitol) were used to detect cytochrome c by Western blot
analysis as described previously62.
Puriﬁcation of H-Ras and Sos1 (residues 564–1049). The open reading frames,
codon optimized for expression in E. coli, for human H-Ras (residues 1–166) and
Sos1 (residues 564–1049) were ordered from Genscript, Inc., and cloned into the
pET28b vector using the NdeI and XhoI restriction sites (Novagen). His-tagged
H-Ras and Sos1 proteins were expressed in E. coli BL21 and puriﬁed by immo-
bilized metal ion afﬁnity chromatography (IMAC) and size-exclusion chromato-
graphy as described previously40. The His-tag was either kept or cleaved off by
TEV protease (12 h at 4 °C), after which the uncleaved protein was removed by a
second IMAC.
Biolayer Interferometry (BLI) experiments. Biolayer interferometry measure-
ments were performed using an Octet Red96 (Forte Bio, Inc.) system at 25 °C,
shaking at 1000 rpm and in a buffer containing 25 mM Hepes pH 7.5, 0.15 M NaCl
and 0.01 M MgCl2. To monitor disruption of the H-Ras/Sos1 complex by
Fru1,6bisP, in a ﬁrst step the Ni2+-coated biosensors were equilibrated in buffer
and a baseline was collected for 30 s. Subsequently the biosensors were loaded with
his-tagged H-Ras at a concentration of 12.5 µg/mL. After another baseline acqui-
sition (200 s) Sos1 (residues 564–1049) was added at 0.5 µM (200 s). Finally, the
biosensors were transferred to wells containing buffer supplemented with
increasing concentrations of Fru1,6bisP and dissociation of the H-Ras/Sos1 com-
plex was monitored for 700 s. All samples were prepared and measured in tripli-
cate. To obtain an apparent dissociation constant (dependent on the dissociation
kinetics of the complex) the signal 150 s after transfer to Fru1,6bisP was plotted vs.
the Fru1,6bisP concentration. The resulting titration curve was ﬁtted on a Lang-
muir equation. A similar procedure was used to study the effect of Fru6P, DHAP,
GAP and glucose on the Ras/Sos1 complex.
Fluorescence-based thermal shift assay. Thermal shift assays (TSA) were per-
formed with Sos1 (residues 564–1049) and H-Ras in presence of increasing con-
centrations of Fru1,6bisP. Thermal unfolding was detected by following SYPRO
orange ﬂuorescence using a CFX connect Real-Time PCR System (Bio-Rad). 0.2
mg/mL of either protein was combined with 5X SYPRO Orange Protein Gel Stain
(Thermo Fisher Scientiﬁc) at concentrations of Fru1,6bisP ranging from 0mM to
100 mM, in a ﬁnal volume of 20 µl. Fluorescence was measured from
20 °C to 80 °C at a rate of 0.5 °C/30 s. All samples were prepared and measured in
triplicate. The melting temperatures Tm were determined by ﬁtting the ﬁrst deri-
vatives of the data using Prism with a Gaussian distribution/Boltzmann sigmoidal
equation. The Tm values were plotted vs. the added ligand concentrations and these
binding curves were analyzed using Prism and ﬁtted with a Langmuir-binding
model.
Reproducibility of the results. All experiments were repeated at least three times
with consistent results.
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Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article and its Supplementary Information ﬁles and
from the corresponding author upon reasonable request.
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